We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+1.83%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$247M
(+32%)
Cap. Flow
-$496M
Cap. Flow
% of AUM
-48.88%
Top 10 Holdings %
Top 10 Hldgs %
63.97%
Holding
140
New
46
Increased
31
Reduced
3
Closed
42
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$12M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$5.48M |
| 3 |
OTIC
Otonomy, Inc.
OTIC
|
+$3.27M |
| 4 |
Insmed
INSM
|
+$2.74M |
| 5 |
FNSR
Finisar Corp
FNSR
|
+$2.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$14.9M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
+$1.64M |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$1.15M |
| 4 |
Allied World Assurance Co Hld Lt
AWH
|
+$825K |
| 5 |
Mobileye N.V.
MBLY
|
+$691K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.88% |
| 2 | Healthcare | 3.4% |
| 3 | Communication Services | 0.4% |
| 4 | Technology | 0.31% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DISCK
76
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $223K | 0.02% |
+11,000
| New | +$247K |
2017 Q3
0 quarters
|
|
|
MXPT
77
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $208K | 0.02% |
+15,001
| New | +$140K |
2017 Q3
0 quarters
|
|
|
DMTX
78
DELISTED
Dimension Therapeutics, Inc
DMTX
| $150K | 0.01% |
+25,000
| New | +$64.8K |
2017 Q3
0 quarters
|
|
|
TERP
79
DELISTED
TerraForm Power, Inc
TERP
| $132K | 0.01% |
+10,000
| New | +$130K |
2017 Q3
0 quarters
|
|
|
SVA
80
DELISTED
Sinovac Biotech, Ltd
SVA
| $106K | 0.01% |
15,000
+5,000
| +50% | +$34.1K |
2017 Q2
1 quarter
|
|
81
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $99K | 0.01% |
20,795
| – | – |
2017 Q1
2 quarters
|
|
|
YUME
82
DELISTED
YuMe, Inc.
YUME
| $46K | ﹤0.01% |
+10,000
| New | +$46.9K |
2017 Q3
0 quarters
|
|
83
Globalstar
GSAT
$10.7B
| $41K | ﹤0.01% |
1,667
+667
| +67% | +$19.3K |
2017 Q2
1 quarter
|
|
|
NMRX
84
CALL
DELISTED
Numerex Corp
NMRX
| $38K | ﹤0.01% |
+10,000
| New | +$41.5K |
2017 Q3
0 quarters
|
|
|
RT
85
DELISTED
Ruby Tuesday Georgia
RT
| $21K | ﹤0.01% |
10,000
| – | – |
2017 Q2
1 quarter
|
|
|
RAD
86
DELISTED
Rite Aid Corporation
RAD
| $20K | ﹤0.01% |
+500
| New | +$23.7K |
2017 Q3
0 quarters
|
|
|
87
Arista Networks
ANET
$234B
| – | – |
-1,588,832
| Closed | -$14.9M | – |
|
|
88
PUT
Arista Networks
ANET
$234B
| – | – |
-3,032,000
| Closed | -$28.4M | – |
|
89
PUT
DELISTED
DigitalBridge
DBRG
| – | – |
-27,750
| Closed | -$1.56M | – |
|
90
PUT
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-48,500
| Closed | -$488K | – |
|
91
PUT
Howmet Aerospace
HWM
$87.6B
| – | – |
-260,800
| Closed | -$4.53M | – |
|
92
CALL
Lipocine
LPCN
$13.9M
| – | – |
-11,329
| Closed | -$776K | – |
|
93
CALL
Lattice Semiconductor
LSCC
$15.2B
| – | – |
-10,300
| Closed | -$69K | – |
|
94
CALL
Palisade Bio
PALI
$268M
| – | – |
-4
| Closed | -$2.1M | – |
|
|
95
PUT
Palisade Bio
PALI
$268M
| – | – |
-3
| Closed | -$1.6M | – |
|
96
CALL
Rocket Pharmaceuticals
RCKT
$259M
| – | – |
-124,175
| Closed | -$934K | – |
|
97
CALL
DELISTED
Sage Therapeutics
SAGE
| – | – |
-307,000
| Closed | -$24.4M | – |
|
|
98
PUT
DELISTED
Sage Therapeutics
SAGE
| – | – |
-5,400
| Closed | -$430K | – |
|
99
CALL
Tvardi Therapeutics
TVRD
$14.3M
| – | – |
-1,558
| Closed | -$864K | – |
|
|
100
PUT
Tvardi Therapeutics
TVRD
$14.3M
| – | – |
-6,250
| Closed | -$3.46M | – |
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, DLD Asset Management held 140 positions worth $1.02B, up 32% from $768M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
DLD Asset Management withdrew a net $496M in Q3 2017, closing 42 positions and reducing 3 holdings. Its most notable exit was Arista Networks, an estimated $14.9M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, DLD Asset Management opened a new position in PTC Therapeutics worth $12.3M.
- DLD Asset Management's largest Q3 2017 buy was PTC Therapeutics: 612,543 shares worth $12.3M.
- DLD Asset Management added most to Insmed in Q3 2017, an estimated $2.74M increase.
- DLD Asset Management's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $138K.
- DLD Asset Management fully exited Arista Networks in Q3 2017, selling an estimated $14.9M.
- DLD Asset Management's ten largest holdings make up 64% of its $1.02B portfolio in Q3 2017.
- DLD Asset Management opened 46 new positions and closed 42 in Q3 2017.
- DLD Asset Management's portfolio value rose 32% quarter-over-quarter to $1.02B.
Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.